Establishing risk of human experimentation with drugs: lessons from TGN1412

Lancet. 2006 Oct 14;368(9544):1387-91. doi: 10.1016/S0140-6736(06)69562-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / metabolism
  • Antibodies, Monoclonal, Humanized
  • Biotechnology / trends*
  • Clinical Trials as Topic / ethics
  • Clinical Trials as Topic / methods*
  • Human Experimentation*
  • Humans
  • Interleukins / biosynthesis
  • Macaca mulatta
  • Molecular Sequence Data
  • Risk Assessment*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukins
  • TGN-1412

Associated data

  • GENBANK/ABG77997
  • GENBANK/ABG77998